Details for Patent: 9,597,399
✉ Email this page to a colleague
Which drugs does patent 9,597,399 protect, and when does it expire?
Patent 9,597,399 protects BENDEKA and is included in one NDA.
This patent has forty-eight patent family members in sixteen countries.
Summary for Patent: 9,597,399
Title: | Formulations of bendamustine |
Abstract: | Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter administration time without the active ingredient coming out of solution as compared to presently available formulations. |
Inventor(s): | Sundaram; Srikanth (Somerset, NJ) |
Assignee: | EAGLE PHARMACEUTICALS, INC. (Woodcliff Lakes, NJ) |
Application Number: | 15/008,827 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,597,399 |
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
Drugs Protected by US Patent 9,597,399
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eagle Pharms | BENDEKA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 208194-001 | Dec 7, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | FOR THE TREATMENT OF PATIENTS WITH INDOLENT B-CELL NON-HODGKIN LYMPHOMA | ⤷ Try a Trial | ||||
Eagle Pharms | BENDEKA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 208194-001 | Dec 7, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,597,399
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2867295 | ⤷ Try a Trial | |||
Canada | 2867343 | ⤷ Try a Trial | |||
China | 104271135 | ⤷ Try a Trial | |||
China | 104302291 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |